Original Article
Full Access
Genetic factors influencing apolipoprotein AI and AII levels in a kindred with premature coronary heart disease
Dr. Ingrid B. Borecki,
Peter Laskarzewski,
DC Rao,
Roger R. Williams,
Corresponding Author
Dr. Ingrid B. Borecki
Division of Biostatistics, Cincinnati
Division of Biostatistics, Box 8067, 660 S. Euclid Avenue, St. Louis, MO 63110Search for more papers by this authorPeter Laskarzewski
Washington University School of Medicine, St. Louis, and University of Cincinnati, Cincinnati
Search for more papers by this authorDC Rao
Division of Biostatistics, Cincinnati
Departments of Psychiatry and Genetics, Cincinnati
Search for more papers by this authorDr. Ingrid B. Borecki,
Peter Laskarzewski,
DC Rao,
Roger R. Williams,
Corresponding Author
Dr. Ingrid B. Borecki
Division of Biostatistics, Cincinnati
Division of Biostatistics, Box 8067, 660 S. Euclid Avenue, St. Louis, MO 63110Search for more papers by this authorPeter Laskarzewski
Washington University School of Medicine, St. Louis, and University of Cincinnati, Cincinnati
Search for more papers by this authorDC Rao
Division of Biostatistics, Cincinnati
Departments of Psychiatry and Genetics, Cincinnati
Search for more papers by this authorAbstract
A single 51-member kindred, ascertained on the basis of a normotriglyceridemic proband with depressed high-density lipoprotein cholesterol (HDL-C) and myocardial infarctions at ages 40 and 42, was studied with respect to quantitative variation in HDL-C and apolipoprotein (apo) AI and AII levels. The results of bivariate segregation analysis suggest that the etiology of depressed HDL-C involves one or possibly two major loci: one has a pleiotropic effect on apo AI and apo AII levels and, possibly another one that affects apo AI levels. Both the major loci were characterized as having a dominant allele leading to depression of the respective trait(s). In addition, analysis of the cosegregation of HDL-C and apo AI levels gave evidence of residual nonfamilial factors common to both traits, leading to a positive covariance between them. This could reflect the role of apo AI in the transformation of nascent HDL-C particles into mature ones via its cofactor activity to lecithin cholesterol acyltransferase. The proposed two-locus model represents one possible etiology for the heterogeneous disorder of hypoal-phalipoproteinemia. This analysis of a single pedigree does not completely define the genetic mechanism, but it does illustrate a useful new analytic approach.
References
- Akaike H (1974): A new look at the statistical model identification. IEEE Trans Automat Control AC-19: 719–723.
- Amos CI, Wilson AF, Rosenbaum PA, Srinivasan SR, Webber LS, Elston RC, Berenson GS (1986): An approach to the multivariate analysis of high density lipoprotein cholesterol in a large kindred: The Bogalusa Heart Study. Genet Epidemiol 3: 255–268.
- Anderson RA, Benda TJ, Wallace RB, Eliason SL, Lee J, Burns TL (1986): Prevalence and associations of apolipoprotein A-I linked DNA polymorphisms: Results from a population study. Genet Epidemiol 3: 385–398.
- Avogaro P, Bittolo Bon, G, Cassolato G, Rorai E (1980): Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction. Atherosclerosis 37: 69–76.
- Borecki IB, Melser MA, Laskarzewski P, Rao DC (1988): Major gene depression of apolipoprotein AI, AII, and high density lipoprotein cholesterol in a four generation, 51 member kindred. Metabolism, in press.
- Borecki IB, Rao DC, Third JLHC, Laskarzewski PM, Glueck CJ (1986): A major gene for primary hypoalphalipoproteinemia. Am J Hum Genet 38: 373–381.
- Breslow JL (1985): Human apolipoprotein molecular biology and genetic variation. Annu Rev Biochem 54: 699–727.
- Byard PJ, Borecki IB, Glueck CJ, Laskarzewski PM, Third JLHC, Rao DC (1984): A genetic study of hypoalphalipoproteinemia. Genet Epidemiol 1: 43–52.
- Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zuigi WJ (1977): HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55: 767–772.
- Castelli WP, Garrison RJ, Wilson PF, Abbott RD, Kalousdian S, Kannel WB (1986): Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 256: 2835–2838.
-
Daniels SR,
Bates S,
Lukin R,
Benton C,
Third JHLC,
Glueck CJ
(1982):
Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke.
Stroke
1:
360–365.
10.1161/01.STR.13.3.360 Google Scholar
- Freedman DS, Srinivasan SR, Shear CL, Franklin FA, Webber LS, Berenson GS (1986): The relation of apolipoprotein A-I and B in children to parental myocardial infarction. N Engl J Med 315: 721–726.
- Friedlander Y, Kark JD, Stein Y (1986): Complex segregation analysis of low levels of plasma highdensity lipoprotein cholesterol in a sample of nuclear familes in Jerusalem. Genet Epidemiol 3: 285–298.
- Hasstedt SJ, Albers JJ, Cheung MC, Jorde LB, Wilson DE, Edwards CQ, Cannon WN, Ash KO Williams RR (1984): The inheritance of high density lipoprotein cholesterol and apolipoproteins A-I and A-II. Atherosclerosis 51: 21–29.
- Hasstedt SJ, Ash KO, Williams RR (1986): A re-examination of major locus hypotheses for high density lipoprotein cholesterol level using 2,170 persons screened in 55 Utah pedigrees. Am J Med Genet 24: 57–67.
- Jahn C, Osborne JCJr, Schaefer EJ, Brewer HBJr (1981): In vitro activation of the enzymic activity of hepatic lipase by apo AII. FEBS Lett 131: 366–368.
- Karathanasis SK, Norum RA, Zannis VI, Breslow JL (1985): An inherited polymorphism in the human apolipoprotein A-I gene locus related to the development of atherosclerosis. Nature 301: 718–720.
- Kottke BA, Zinsmeister AR, Holmes RW, Kneller RW, Hallaway BJ, Mao SJT (1986): Apolipoproteins and coronary artery disease. Mayo Clin Proc 61: 313–320.
- Lalouel JM, (1983): Segregation analysis of familial data. In NE Morton, DC Rao, JM Lalouel (eds): “ Methods in Genetic Epidemiology.” Basel: S. Karger, pp 75–97.
- Lalouel JM, LeMignon L, Simon M, Fauchet R, Bourel M, Rao DC, Morton NE (1985): A combined qualitative (disease) and quantitative (serum iron) genetic analysis of idiopathic hemochromatosis. Am J Hum Genet 37: 700–718.
- Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJT (1983): Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med 309: 385–389.
- MacLean CJ, Morton NE, Elston RC, Yee S (1976): Skewness in commingled distributions. Biometrics 32: 694–699.
- Malloy MJ, Kane JP (1982) Hypolipidemia. Med Clin North Am 66: 469–484.
- Manual of Laboratory Operation (1974): Lipid Research Clinics Program (Vol. 1). Lipid and Lipoprotein Analysis. DHEW Publications (NIH 75–678 US Government Printing Office. Washington, DC.
- Mendoza SG, Kerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML (1983): Estradiol, testosterone apolipoproteins, lipoprotein cholesterol, lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery 12: 1–23.
- Miller GJ, Miller NE (1975): Plasma high density lipoprotein concentration in development of ischemic heart disease. Lancet 1: 16–19.
- Moll PP, Sing CF, Williams RR, Mao SJT, Kottke BA (1986): The genetic determination of plasma apolipoprotein A-I levels measured by radioimmunoassay: A study of high risk pedigrees. Am J Hum Genet 38: 361–372.
- Morton NE, Gulbrandsen CL, Rhoads GG, Kagan A, Lew R (1978): Major loci for lipoprotein concentrations. Am J Hum Genet 30: 583–589.
- Namboodiri KK, Bucher KD, Kaplan EB, Laskarzewski PM, Glueck CJ, Rifkind BM (1985): A major gene for low levels of high density lipoprotein cholesterol: The collaborative Lipid Research Clinics Family Study. Clin Res 33: 890A.
- Namboodiri KK, Kaplan EB, Heuch I, Elston RC, Green PP, Rao DC, Laskarzewski P, Glueck CJ, Rifkind BM (1985): The collaborative lipid research clinics family study: Biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol 2: 227–254.
- Norum RA, Lakier JB, Goldstein S, Angel A, Goldberg RB, Block WD, Noffze DK, Dolphin PJ, Edelglass J, Bogard DD, Alaupovic P (1982): Familial deficiency of apoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med 306: 1513–1519.
- Ordovas JM, Schaeffer EJ, Salem D, Ward RH, Glueck CJ, Vergani C, Wilson PWF, Karathanasis SK (1986): Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med 314: 671–677.
- Rao DC, Laskarzewski PM, Morrison JA, Khoury P, Kelly K, Wette R, Russell J, Glueck CJ (1982): The Cincinnati Lipid Research Clinic Family Study: Cultural and biological determinants of lipids and lipoprotein concentrations. Am J Hum Genet 34: 888–903.
- Riesen WF, Mordasini R, Salzmann C, Theler A, Gurtner HP (1980): Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis 37: 157–162.
- Schmidt SB, Wasserman AG, Muesing RA, Schlesselmann SE, Larosa JC, Ross AM (1985): Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol 55: 1459–1462.
- Stein EA, Pesce A (1983): Enzyme linked immunoassays for apolipoproteins: Advantages, problems, and prototype assay. In K Lippel (ed): “ Proceedings of the Workshop on Apolipoprotein Quantification.” US DHEW, NIH publication #83–1266, 319.
- Third JLHC, Montag J, Flynn M, Freidel J, Laskarzewski P, Glueck CJ (1984): Primary and familial hypoalphalipoproteinemia. Metabolism 33: 136–146.
- Zannis VI, Breslow JL (1985): Genetic mutations affecting human lipoprotein metabolism. Adv Hum Genet 14: 125–215.
